QLT Publishes Data From Phase 1b Trial Of QLT091001 In Subjects With Leber Congenital Amaurosis In The Lancet Journal
July 14, 2014 at 07:12 AM EDT
QLT Inc. (Nasdaq: QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the publication of data from its Phase 1b proof-of-concept ...